Table 3.

Isatuximab and LEN plasma PK parameters

Mean ± SD (geometric mean) [CV%]Isatuximab, single IV infusionLEN 25 mg, single and repeated oral administration
3 mg/kg Q2W (n = 2)5 mg/kg Q2W (n = 3)10 mg/kg Q2W (n = 17)10 mg/kg QW (n = 7)20 mg/kg QW (n = 5)Day 1 (n = 29)Day 15 (n = 14)
Cmax, μg/mL 68.3 ± NC (67.8) [NC] 98.1 ± 49.7 (90.7) [51] 212 ± 96.5 (193) [46] 122 ± 29 (119) [24] 257 ± 133 (232) [52] 315 ± 129 (285) [41] 347 ± 147 (316) [42] 
tmax,*6.10 (3.25-9.87) 3.90 (2.75-5.65) 5.75 (2.25-11.17) 6.0 (2.70-21.92) 8.72 (5.10-24.0) 2.00 (0.92-4.25) 2.24 (0.58-8.25) 
AUC0-1wk, μg·h/mL 4240 ± NC (3940) [NC] 6560 ± 3110 (6120) [47] 15 800 ± 6 690 (14 400) [42] 10 100 ± 2 690 (9800) [38] 20 300 ± 7 740 (19 000) [38] NC NC 
AUC0-2wk, μg·h/mL 5080 ± NC (4560) [NC] 8360 ± 4560 (7620) [55] 21 700 ± 10 100 (19 100) [46] NC NC NC NC 
AUC0-24h, ng·h/mL NC NC NC NC NC 2720 ± 1460 (2370) [54] 2950 ± 1290 (2720) [44] 
Mean ± SD (geometric mean) [CV%]Isatuximab, single IV infusionLEN 25 mg, single and repeated oral administration
3 mg/kg Q2W (n = 2)5 mg/kg Q2W (n = 3)10 mg/kg Q2W (n = 17)10 mg/kg QW (n = 7)20 mg/kg QW (n = 5)Day 1 (n = 29)Day 15 (n = 14)
Cmax, μg/mL 68.3 ± NC (67.8) [NC] 98.1 ± 49.7 (90.7) [51] 212 ± 96.5 (193) [46] 122 ± 29 (119) [24] 257 ± 133 (232) [52] 315 ± 129 (285) [41] 347 ± 147 (316) [42] 
tmax,*6.10 (3.25-9.87) 3.90 (2.75-5.65) 5.75 (2.25-11.17) 6.0 (2.70-21.92) 8.72 (5.10-24.0) 2.00 (0.92-4.25) 2.24 (0.58-8.25) 
AUC0-1wk, μg·h/mL 4240 ± NC (3940) [NC] 6560 ± 3110 (6120) [47] 15 800 ± 6 690 (14 400) [42] 10 100 ± 2 690 (9800) [38] 20 300 ± 7 740 (19 000) [38] NC NC 
AUC0-2wk, μg·h/mL 5080 ± NC (4560) [NC] 8360 ± 4560 (7620) [55] 21 700 ± 10 100 (19 100) [46] NC NC NC NC 
AUC0-24h, ng·h/mL NC NC NC NC NC 2720 ± 1460 (2370) [54] 2950 ± 1290 (2720) [44] 

Cmax, maximum observed concentration; NC, not calculated; tmax, time to reach Cmax.

*

Median (range).

n = 27.

n = 13.

Close Modal

or Create an Account

Close Modal
Close Modal